Details for Patent: 7,115,587
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,115,587 protect, and when does it expire?
Patent 7,115,587 protects ABILIFY and is included in one NDA.
Protection for ABILIFY has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-one patent family members in thirty-one countries.
Summary for Patent: 7,115,587
|Title:||Aripiprazole complex formulation and method|
|Abstract:||An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a .beta.-cyclodextrin, preferably, sulfobutyl ether .beta.-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided.|
|Inventor(s):||Nerurkar; Manoj (Monmouth Junction, NJ), Naringrekar; Vijay (Paramus, NJ)|
|Assignee:||Bristol-Myers Squibb Company (Princeton, NJ)|
Patent Claim Types:|
see list of patent claims
Drugs Protected by US Patent 7,115,587
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use||Submissiondate|
|Otsuka||ABILIFY||aripiprazole||INJECTABLE;INTRAMUSCULAR||021866-001||Sep 20, 2006||DISCN||No||No||See Plans and Pricing||See Plans and Pricing||Y||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Patented / Exclusive Use||>Submissiondate|
International Family Members for US Patent 7,115,587
|Country||Patent Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Argentina||040887||See Plans and Pricing|
|Argentina||102101||See Plans and Pricing|
|Austria||428423||See Plans and Pricing|
|Australia||2003269965||See Plans and Pricing|
|Brazil||0313602||See Plans and Pricing|
|Canada||2495864||See Plans and Pricing|
|China||100335047||See Plans and Pricing|
|>Country||>Patent Number||>Estimated Expiration||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration|